or
forgot password
  • cancer clinical trials in ogden, UT

  • First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Northern Utah Associates
    Ogden, Utah 84403
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis
    Site Ref # / Investigator 5398
    Ogden, Utah 84405
    Ulcerative Colitis
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
    Utah Hematology Oncology, P.C.
    Ogden, Utah 84403
    Non-Hodgkin's Lymphoma
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    Northern Utah Cancer Associates Dept.ofNorthernUtahAssoc.
    Ogden, Utah 84403-3105
    Multiple Myeloma
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Northern Utah Associates
    Ogden, Utah 84403
    Relapsed Follicular Lymphoma
    Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Head and Neck Cancer
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Colorectal Cancer, Metastatic Cancer
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Northern Utah Associates
    Ogden, Utah 84403
    Locally Recurrent or Metastatic Breast Cancer
    An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    Northern Utah Associates
    Ogden, Utah 84403
    Chemotherapy-Induced Nausea and Vomiting
    An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
    Northern Utah Associates [Hematology/ Oncology]
    Ogden, Utah
    Chemotherapy-Induced Nausea and Vomiting